/DMSI

DMSI Stock - Dermisonics, Inc.

Q: What is the analyst price target for DMSI?

Analyst price target information is not currently available for DMSI.

Q: What is DMSI's market cap?

Market capitalization information is not currently available for DMSI.

Healthcare|Medical - Specialties|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for DMSI

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2003

FY2004

FY2005

FY2006

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-244.38

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2006	FY2005	FY2004	FY2003
Revenue	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A
Gross Margin	N/A	N/A	N/A	N/A
Operating Income	$-4,488,275	$-6,200,050	N/A	N/A
Net Income	$-5,084,047	$-6,958,686	$-3,993,148	$-82,501
Net Margin	N/A	N/A	N/A	N/A
EPS	$-0.12	$-0.17	$-0.27	$-0.00

Company Overview

Dermisonics, Inc. manufactures ultrasonic transdermal drug-delivery technologies and equipment. It primarily focuses on the development, testing, and commercialization of its active transdermal patch, called the U-Strip, that has been designed to facilitate the needle-free delivery of drugs with large molecular structures, such as Insulin into the bloodstream. The company was formerly known as Second Stage Ventures, Inc. and changed its name to Dermisonics, Inc. in October 2004. Dermisonics, Inc. was founded in 2000 and is based in Irvine, California.

Frequently Asked Questions about DMSI

What is DMSI's current stock price?

Dermisonics, Inc. (DMSI) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for DMSI?

No analyst price targets are currently available for this stock.

What sector is Dermisonics, Inc. in?

Dermisonics, Inc. operates in the Healthcare sector, specifically within the Medical - Specialties industry. The company is traded on the OTC exchange.

What is DMSI's market cap?

Dermisonics, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does DMSI pay dividends?

No, Dermisonics, Inc. does not currently pay a dividend to shareholders.